Esophageal Squamous Cell Carcinomas
5 clinical trials · Condition
◉ Watch Esophageal Squamous Cell Carcinomas
| Record | Firm | Date |
|---|---|---|
| SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma. (NCT05022654) | Sichuan Baili Pharmaceutical Co., Ltd. | 2021-12-13 |
| Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy (NCT05103501) | Shanghai Chest Hospital | 2021-12-01 |
| Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery (NCT04741490) | Fuzhou General Hospital | 2021-02-01 |
| Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma (NCT02611700) | Biotech Pharmaceutical Co., Ltd. | 2015-11-01 |
Track Esophageal Squamous Cell Carcinomas automatically
Every clearance here is in the API, with alerts when new ones post.